DOUBLE-BLIND, CROSSOVER PLACEBO CONTROLLED TRIAL OF SELEGILINE IN PARKINSONS-DISEASE - AN INTERIM ANALYSIS

被引：11
|
作者：
TEYCHENNE, PF
PARKER, S
机构：
[1] BALMAIN HOSP,SYDNEY,AUSTRALIA
[2] ROZELLO HOSP,SYDNEY,AUSTRALIA
[3] RECKITT & COLMAN PHARMACEUT,W RYDE,NSW,AUSTRALIA
[4] NEW S WALES INST PSYCHIAT,SYDNEY,NSW,AUSTRALIA
来源：
ACTA NEUROLOGICA SCANDINAVICA | 1989年 / 80卷
关键词：
D O I：
10.1111/j.1600-0404.1989.tb01791.x
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：119 / 125
页数：7
相关论文
共 50 条
  • [21] DOUBLE-BLIND CONTROLLED-STUDY OF PERGOLIDE MESYLATE IN THE TREATMENT OF PARKINSONS-DISEASE
    OLANOW, CW
    ALBERTS, MJ
    CLINICAL NEUROPHARMACOLOGY, 1987, 10 (02) : 178 - 185
  • [22] RANDOMIZED, DOUBLE-BLIND TRIAL OF EXIFONE VERSUS COGNITIVE PROBLEMS IN PARKINSONS-DISEASE
    ALLAIN, H
    DENMAT, J
    BENTUEFERRER, D
    MILON, D
    PIGNOL, P
    REYMANN, JM
    PAPE, D
    SABOURAUD, O
    VANDENDRIESSCHE, J
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1988, 2 (01) : 1 - 12
  • [23] BORNAPRINE VS PLACEBO IN PARKINSON DISEASE - DOUBLE-BLIND CONTROLLED CROSSOVER TRIAL IN 30 PATIENTS
    CANTELLO, R
    RICCIO, A
    GILLI, M
    DELSEDIME, M
    SCARZELLA, L
    AGUGGIA, M
    BERGAMASCO, B
    ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1986, 7 (01): : 139 - 143
  • [24] Colchicine versus placebo in Behcet's disease: randomized, double-blind, controlled crossover trial
    Davatchi, Fereydoun
    Abdollahi, Bahar Sadeghi
    Banihashemi, Arash Tehrani
    Shahram, Farhad
    Nadji, Abdolhadi
    Shams, Hormoz
    Chams-Davatchi, Cheyda
    MODERN RHEUMATOLOGY, 2009, 19 (05) : 542 - 549
  • [25] A Randomized Double-Blind Placebo-Controlled Phase III Trial of Selegiline Monotherapy for Early Parkinson Disease
    Mizuno, Yoshikuni
    Hattori, Nobutaka
    Kondo, Tomoyoshi
    Nomoto, Masahiro
    Origasa, Hideki
    Takahashi, Ryosuke
    Yamamoto, Mitsutoshi
    Yanagisawa, Nobuo
    CLINICAL NEUROPHARMACOLOGY, 2017, 40 (05) : 201 - 207
  • [26] A double-blind placebo-controlled randomised trial of pregabalin for alcohol dependence: interim analysis
    Krupitsky, E.
    Rybakova, K.
    Skurat, E.
    Kiselev, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S663 - S664
  • [27] A double-blind, placebo controlled trial of implantable naltrexone for heroin dependence: results of interim analysis
    Krupitsky, E.
    Zvartau, E.
    Woody, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S532 - S532
  • [28] CROSSOVER TRIAL OF RO 19-6327 AND SELEGILINE IN OTHERWISE UNTREATED PARKINSONS-DISEASE
    SEGEL, SA
    LEWITT, PA
    MISTURA, KL
    SCHORK, MA
    NEUROLOGY, 1993, 43 (04) : A333 - A333
  • [29] CONTROLLED-RELEASE SINEMET (CR-4) - A DOUBLE-BLIND CROSSOVER STUDY IN PATIENTS WITH FLUCTUATING PARKINSONS-DISEASE
    AHLSKOG, JE
    MUENTER, MD
    MCMANIS, PG
    BELL, GN
    BAILEY, PA
    MAYO CLINIC PROCEEDINGS, 1988, 63 (09) : 876 - 886
  • [30] DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF LEVODOPA THERAPY IN PARKINSONS DISEASE
    MUENTER, MD
    NEUROLOGY, 1970, 20 (12) : 6 - &
12345